[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"diet\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:diet":32},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,13,0,[8,53,80,126,152,183,214,245,318,348,376,408,434],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":20,"enrollmentInfo":21,"targetDuration":4,"studyType":24,"phases":25,"briefSummary":27,"conditions":28,"keywords":33,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":41,"lastUpdatePostDateStruct":42,"startDateStruct":45,"completionDateStruct":47,"leadSponsor":49,"locationsCount":52},"100644813","dietary-macronutrients-and-gut-microbiota-inflammation-and-metabolic-markers-100644813",false,"NCT07672691","Dietary Macronutrients and Gut Microbiota, Inflammation, and Metabolic Markers","Effects of Diets Differing in Macronutrient Composition on Gut Microbiota Composition, Intestinal Inflammation Markers, Gene Expression Profiles, and Blood Biochemical Parameters in Diverse Populations.","DIETMICRO","Inclusion Criteria:\n\nIn addition to the physical activity requirements described above, the study will include men and women aged 18-60 years with:\n\nBMI not exceeding 40kg\u002Fm²\n\nHabitual mixed diet prior to study enrollment\n\nNormal blood pressure\n\n* Exclusion Criteria:\n\nPoprawiłem już \\*\\*Exclusion Criteria\\*\\* w poprzedniej odpowiedzi - wszystkie te kryteria już tam są wpisane. Oto pełna, ostateczna wersja z wszystkimi wskazanymi kryteriami wyłączenia:\n\n\\*\\*\\* \\*\\*Exclusion Criteria:\\*\\*\n\n* Use of medications regulating \\*\\*glucose levels\\*\\* (e.g., metformin) or \\*\\*blood lipids\\*\\* (e.g., \\*\\*statins\\*\\*)\n* \\*\\*Hypertension\\*\\* or pharmacological treatment for hypertension\n* Diagnosed \\*\\*gastrointestinal disorders\\*\\*, including:\n* Gastric and duodenal ulcers\n* \\*\\*Irritable bowel syndrome (IBS)\\*\\*\n* \\*\\*Ulcerative colitis\\*\\*\n* \\*\\*Celiac disease\\*\\*\n* Chronic use of medications such as:\n* \\*\\*Mesalazine\\*\\*\n* \\*\\*Corticosteroids\\*\\*\n* \\*\\*Statins\\*\\*\n* \\*\\*Proton pump inhibitors (PPI)\\*\\*\n* \\*\\*Non-steroidal anti-inflammatory drugs (NSAIDs)\\*\\*\n* \\*\\*Anticonceptional medications\\*\\*\n* \\*\\*Any supplements\\*\\*\n* \\*\\*Alcohol consumption\\*\\* \\> 2 times\u002Fweek with \\> 15 g alcohol per occasion (approximately 15 g alcohol = 330 mL beer, 150 mL dry red wine, or 50 mL vodka)\n* \\*\\*Smoking cigarettes\\*\\*\n* Following a \\*\\*ketogenic diet\\*\\* or \\*\\*vegetarian diet\\*\\* within \\*\\*1 month\\*\\* prior to study enrollment",true,"ALL","18 Years","60 Years",{"count":22,"type":23},200,"ESTIMATED","INTERVENTIONAL",[26],"NA","Poniżej znajduje się bardziej płynna i mniej powtarzalna wersja tekstu:\n\nThis 12-week randomized controlled trial will investigate the effects of dietary patterns with different macronutrient compositions on gut microbiota, intestinal inflammation, gene expression, and metabolic health in healthy adults.\n\nParticipants will be randomly assigned to one of three dietary interventions: a ketogenic diet (KD), a vegetarian diet (VD), or a control diet (CD) reflecting their habitual mixed dietary pattern. Adherence to the assigned diet will be monitored through dietary records and regular nutritional counseling.\n\nThe study will evaluate changes in gut microbiota composition, inflammatory biomarkers, transcriptomic profiles, and blood biochemical parameters associated with lipid and glucose metabolism. Blood and stool samples will be collected at predefined time points throughout the intervention, while participants in the KD group will additionally undergo ketone monitoring to assess dietary compliance.\n\nBy comparing the ketogenic and vegetarian diets with a standard mixed diet, this study aims to determine their effects on gut health, metabolic function, and systemic inflammation, thereby providing evidence to inform dietary recommendations.\n\nTa wersja eliminuje powtórzenia (\"diet\", \"study\", \"monitor\", \"effects\"), jest bardziej naturalna stylistycznie i odpowiada standardowi językowemu publikacji w czasopismach z zakresu żywienia i medycyny.",[29,30,31,32],"Nutrition","Ketogenic Diet","Gene Expression","Diet",[34,35,36,37,38,39],"ketogenic diet","gene expression","transcriptomics","biochemical parameters","stool microbiome","ketone bodies","RECRUITING","2026-07-01",{"date":43,"type":44},"2026-07-02","ACTUAL",{"date":46,"type":44},"2024-09-02",{"date":48,"type":23},"2028-12-30",{"name":50,"class":51},"The Jerzy Kukuczka Academy of Physical Education in Katowice","OTHER",2,{"id":54,"slug":55,"hasResults":11,"nctId":56,"briefTitle":57,"officialTitle":57,"acronym":58,"eligibilityCriteria":59,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":60,"enrollmentInfo":61,"targetDuration":4,"studyType":24,"phases":63,"briefSummary":64,"conditions":65,"keywords":66,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":79},"100630762","identification-of-objective-metabolomics-based-biomarkers-of-yogurt-consumption-100630762","NCT07491887","Identification of Objective Metabolomics-based Biomarkers of Yogurt Consumption","YOGBIO","Inclusion criteria:\n\n* age: 18-70 years;\n* BMI: 18-40 kg\u002Fm²;\n* willingness to consume plain yogurt daily for 3 weeks;\n* for coffee\u002Ftea consumers, willingness to consume these beverages without added milk, cream or sugar for 4 weeks.\n\nExclusion criteria:\n\n* lactose intolerance; blood donation within 2 months; severe chronic illness or ongoing treatment for conditions such as infections, autoimmune diseases, cancer, type 2 diabetes, Crohn's disease, celiac disease, hepatic or renal diseases;\n* history of severe cancer, cardiovascular disease or bariatric surgery;\n* unstable body weight for 3 months;\n* illicit drug use or alcoholism; tobacco\u002Fcannabis smoking\u002Fvaping (ensuring no day-to-day fluctuations and objective reporting of consumption is too complex);\n* allergies or aversions to components of the diets.","70 Years",{"count":62,"type":23},16,[26],"Substantial evidence links yogurt consumption to a lower risk of type 2 diabetes (T2D). However, the existing evidence is derived exclusively from prospective cohort studies relying on self-reported dietary questionnaires, which-despite being validated-are subject to random and systematic errors that may compromise evidence quality and hinder regulatory approval.\n\nThe project aims to discover and validate biomarkers of yogurt intake.\n\nThe investigators will conduct a randomized, crossover, dose-response feeding trial involving 16 generally healthy adult participants (8 females, 8 males). The trial will include four 7-day diet periods, each separated by a 1-week washout. All diets will be based on a dairy-free background and supplemented with one of the following: (a) 1 serving of soy-based pudding (no yogurt), (b) 0.5 serving of yogurt, (c) 1 serving of yogurt, or (d) 2 servings of yogurt per 2,380 kcal\u002Fday.\n\nOn the 7th day of each diet, participants will complete a mixed-meal test at INAF, consuming a smoothie containing the same yogurt dose as during the preceding days. Plasma samples collected in the postprandial state will be used to profile over 20,000 metabolites. Using artificial intelligence-based approaches, potential biomarkers of yogurt intake will be identified. These candidates will then be filtered using standard statistical methods to assess dose- and time-responsiveness, robustness, and biological plausibility. Biomarkers that meet all criteria will be considered validated indicators of yogurt intake.",[32],[67,68],"yogurt","biomarker of food intake","NOT_YET_RECRUITING","2026-03-27",{"date":72,"type":44},"2026-04-02",{"date":74,"type":23},"2026-03-23",{"date":76,"type":23},"2026-06-30",{"name":78,"class":51},"Laval University",1,{"id":81,"slug":82,"hasResults":11,"nctId":83,"briefTitle":84,"officialTitle":85,"acronym":4,"eligibilityCriteria":86,"healthyVolunteers":11,"sex":18,"minAge":87,"maxAge":88,"enrollmentInfo":89,"targetDuration":4,"studyType":24,"phases":91,"briefSummary":92,"conditions":93,"keywords":109,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":119,"startDateStruct":120,"completionDateStruct":122,"leadSponsor":124,"locationsCount":79},"100572617","wild-blueberries-for-gut-brain-and-heart-health-in-adults-with-high-blood-pressure-100572617","NCT06735599","Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure","Effects of Wild Blueberry Consumption on Gut, Brain, and Cardiovascular Health in Non-Hispanic Black and White Adults With High Blood Pressure","Inclusion Criteria:\n\n* Individuals 45-65 years of age\n* Diagnosis of elevated blood pressure or stage 1 hypertension (systolic blood pressure = 120-139 mmHg and\u002For diastolic blood pressure = 80-89 mmHg) for at least 6 months\n* BMI 25-35 kg\u002Fm2 via anthropometric measurements.\n* Ability to give consent\n\nExclusion Criteria:\n\n* Allergies to berries\n* Use of one hypertensive drug for less than three months\n* Use of more than one anti-hypertensive or statin drug, insulin, antibiotics, and anti-inflammatory drugs, active cancer, gastrointestinal, renal, cardiovascular, thyroid, and neurological disorders or severe head injury\n* Smoking\n* Alcohol consumption (\\>2 drinks\u002Fday)\n* Consuming antioxidant, probiotic, and prebiotic supplements\n* Pregnant or lactating\n* Participating in a weight loss program","45 Years","65 Years",{"count":90,"type":23},40,[26],"The purpose of the study is to determine the effectiveness of wild blueberries on cardiovascular health, cognitive function, and gut microbiota composition in non-Hispanic Black and White adults with elevated blood pressure.",[94,95,96,97,98,99,100,101,32,102,103,104,105,106,107,108],"Hypertension (Without Type 2 Diabetes Mellitus)","High Blood Pressure","Male","Female","Adult","Cognition","Endothelial Function (Reactive Hyperemia)","Oxidative Stress","Overweight","Body Composition Measurement","Gut Microbiome","Arterial Stiffness","Caucasian Whites","Inflammation","Microvascular Function",[110,111,102,95,112,113,114,115,116,117,118],"Blueberries","Hypertension","Endothelial Function","Cognitive Function","Dietary intervention","functional foods","gut microbiota","arterial stiffness","microvascular function",{"date":70,"type":44},{"date":121,"type":44},"2024-09-17",{"date":123,"type":23},"2027-01-01",{"name":125,"class":51},"Georgia State University",{"id":127,"slug":128,"hasResults":11,"nctId":129,"briefTitle":130,"officialTitle":131,"acronym":132,"eligibilityCriteria":133,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":134,"enrollmentInfo":135,"targetDuration":4,"studyType":24,"phases":137,"briefSummary":138,"conditions":139,"keywords":4,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":144,"lastUpdatePostDateStruct":145,"startDateStruct":146,"completionDateStruct":148,"leadSponsor":150,"locationsCount":79},"100581298","using-tailored-mhealth-strategies-to-promote-weight-management-among-adolescent-and-young-adult-cancer-survivors-100581298","NCT06848491","Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors","Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors (AYA Well)","AYAWell","Inclusion Criteria:\n\n* 18-39 years old at the time of consent.\n* Diagnosed with first invasive cancer between ages 15-39 years (self-report).\n* Within 10 years of diagnosis with no evidence of progressive disease or second primary cancers (self-report).\n* Completed active cancer directed therapy (cytotoxic chemotherapy, radiation therapy and\u002For definitive surgical intervention) at least six months prior to enrollment; may be receiving \"maintenance\" therapy to prevent recurrences (self-report).\n* Body mass index (BMI) of 25-50 kg\u002Fm2\n\nExclusion Criteria:\n\n* Type 1 diabetes or currently receiving certain medical treatments for Type 2 diabetes\n* Report a history of heart attack or stroke within previous 6 months\n* Health problems which preclude ability to walk for physical activity (e.g., lower limb amputation). Participants endorsing items 1-4 on the Physical Activity Readiness Questionnaire (PAR-Q) (experience of heart problems, frequent chest pains, or faintness or dizziness) will be excluded from the study.\n* Lost 5% or more of body weight (and kept it off) in the last 3 months\n* Lifetime history of clinical diagnosis or treatment of eating disorder (anorexia nervosa or bulimia nervosa), OR report of compensatory behaviors within the previous 3 months. If participant reports a history of compensatory behaviors, the investigators will review their information to determine eligibility.\n* Currently pregnant, pregnant within the past 6 months, or planning to become pregnant within the next 12 months\n* Untreated thyroid disease or any changes (type or dose) in thyroid medication in last 6 months\n* Hospitalization for depression or other psychiatric disorder within the past 12 months.\n* History of psychotic disorder or uncontrolled bipolar disorder\n* Currently participating in a weight loss, nutrition, or physical activity study or program or other study that would interfere with this study\n* Currently using prescription medications with known effects on appetite or weight (e.g., oral steroids, weight loss medications), with the exception of individuals on a stable dose of SSRIs for 3 months)\n* Previous surgical procedure for weight loss or planned weight loss surgery in the next year\n* Inability to speak and read English\n* Does not reside in the United States\n* Do not have mobile phone with data plan or willing to be contacted by study through text messaging\n* No Internet access\n* Not willing to be randomized to either intervention arm","39 Years",{"count":136,"type":23},240,[26],"The AYA WELL study is a 2-arm randomized clinical trial to test the efficacy of a theory-based, mHealth weight management intervention adapted specifically for adolescent and young adult cancer survivors compared to a self-guided arm. Participants, diagnosed with cancer between ages 15-39, currently age 18-39, post-treatment at least 6 months, and who have overweight or obesity will be randomized to receive either: 1) a comprehensive mHealth weight management program (intervention) or 2) digital tools + health education + peer support (self-guided) over 12 months. Outcomes will be assessed at 3, 6, and 12 months.",[140,141,142,143,32],"Obesity","Cancer","Physical Activity","Cancer Survivorship","2026-03-20",{"date":74,"type":44},{"date":147,"type":44},"2025-10-27",{"date":149,"type":23},"2028-10-31",{"name":151,"class":51},"UNC Lineberger Comprehensive Cancer Center",{"id":153,"slug":154,"hasResults":11,"nctId":155,"briefTitle":156,"officialTitle":157,"acronym":158,"eligibilityCriteria":159,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":88,"enrollmentInfo":160,"targetDuration":4,"studyType":162,"phases":4,"briefSummary":163,"conditions":164,"keywords":167,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":174,"lastUpdatePostDateStruct":175,"startDateStruct":177,"completionDateStruct":179,"leadSponsor":181,"locationsCount":4},"100626951","assessing-dietary-intake-of-selected-food-components-using-short-questionnaires-100626951","NCT07442305","Assessing Dietary Intake of Selected Food Components Using Short Questionnaires","Validation of Short Questionnaires for Assessing Dietary Intake of Selected Food Components","NutriPlant\u002FFFQ","Inclusion criteria:\n\n* Willingness to participate in the study.\n* Signed Statement of Informed and Voluntary Consent to Participate in the Study.\n* Age between 18 and 65 years at the time of enrolment in the study.\n* Willingness to comply with all study procedures and to keep a dietary record in accordance with the provided instructions.\n\nExclusion criteria:\n\n* Pregnancy or breastfeeding.\n* Specific dietary practices followed by a small proportion of the population (veganism, LCHF, calorie-restricted diets; note: vegetarians are not excluded).\n* Diets prescribed by medical professionals.\n* Mental incapacity that prevents adequate understanding or participation.\n\nReasons for excluding a participant during the study:\n\n* Inability to participate in the study\n* Wishes to discontinue participation\n* Incomplete data provided",{"count":161,"type":23},50,"OBSERVATIONAL","The aim of the study is to validate short questionnaires for assessing dietary intake of selected food components, with a focus on dietary fibre and iron. Two internationally developed short questionnaires (FiberScreen \\[for dietary fibre\\] and IRONQ-FFQ \\[for iron\\]) were adapted to the Slovenian context and will be compared with the standard 24-hour dietary recall method.",[165,166,32],"Nutritional Status","Iron-deficiency",[168,169,170,171,172,173],"dietary intake","nutritional status","micronutrients","iron","ffq","food recall","2026-02-27",{"date":176,"type":44},"2026-03-02",{"date":178,"type":23},"2026-03-01",{"date":180,"type":23},"2027-12-31",{"name":182,"class":51},"Institute of Nutrition, Slovenia (Nutris)",{"id":184,"slug":185,"hasResults":11,"nctId":186,"briefTitle":187,"officialTitle":188,"acronym":189,"eligibilityCriteria":190,"healthyVolunteers":11,"sex":18,"minAge":191,"maxAge":192,"enrollmentInfo":193,"targetDuration":4,"studyType":24,"phases":195,"briefSummary":196,"conditions":197,"keywords":200,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":205,"lastUpdatePostDateStruct":206,"startDateStruct":208,"completionDateStruct":210,"leadSponsor":212,"locationsCount":79},"100527811","mind-foods-and-aerobic-training-in-black-adults-with-htn-100527811","NCT06152614","MIND Foods and Aerobic Training in Black Adults With HTN","MIND Foods and Aerobic Training in Black Adults With HTN: An ADRD Prevention Pilot RCT","MAT","Inclusion Criteria:\n\n1. Fluent in English\n2. Marion County resident\n3. 35-75 years\n4. Self-identified non-Hispanic and Black\u002FAfrican-American\u002Fbiracial including African-American\n5. Systolic BP of ≥140 in prior 12 months from a primary care visit\n6. Ability to see and read street signs (self report)\n7. Stable housing with independent access to kitchen, including functional stove or hotplate, oven, refrigerator, and freezer (self report)\n8. Activity independence per functional activities questionnaire (FAQ; \\\u003C3 responses of \"Require Assistance\" and 0 responses of \"Dependent\")\n9. Normal cognition per six-item screener (SIS; score of ≥ 5)\n10. Less than 20min on usual day of moderate or vigorous physical activity\n11. Able to exercise safely per abbreviated Exercise Assessment for You (EASY) or primary care provider clearance\n12. Mean systolic BP of ≥130 from 3 standard BP measurements taken by research staff following standardized wait periods.\n\nExclusion Criteria:\n\n1. lives in nursing home\n2. diagnosis of dementia or Alzheimer disease or mild cognitive impairment; Parkinson disease; brain tumor\u002Finfection\u002Fsurgery (within the last 10 years with residual symptoms and\u002For functional loss\u002Fdeficit, such as impaired learning, memory, or communication); cancer with short life expectancy, or current chemotherapy or radiation therapy; psychosis, schizophrenia, or bipolar disorder\n3. ICD 10 code I11\u002Fhypertensive heart disease, ICD 10 code I12\u002Fhypertensive CKD, ICD 10 code I13\u002Fhypertensive heart disease and CKD, ICD 10 code I15, or ICD 10 code I16\n4. current or past prescription of donepezil, memantine, rivastigmine, or galantamine\n5. alcohol consumption ≥ 8 drinks per week for women, or ≥15 drinks per week for men\n6. drug use\u002Fabuse (excluding marijuana) per EMR\n7. moving out of area during study timeline\n8. scheduling conflicts with intervention schedule\n9. unwilling to use a touchscreen\n10. unwilling to be on video conferencing\n11. low communicative ability, functional status, or other disorders (examiner rated) that would interfere with interventions and assessments\n12. unable to provide informed consent\n13. participation in any lifestyle modification\u002Fweight loss program (e.g., Weight Watchers, etc.)","35 Years","75 Years",{"count":194,"type":23},128,[26],"The goal of this randomized controlled trial is to determine the impact of Mediterranean-Dash Intervention for Neurodegenerative Delay (MIND) diet and aerobic training on cognition in Black adults with high systolic blood pressure.\n\nResearchers will compare Food Delivery and Cooking PLUS Aerobic Training (FoRKS+) versus Enhanced Usual Care (EUC) to evaluate the effects on cognition.\n\nParticipants will complete cognitive and cardiovascular assessments, 24-hr blood pressure monitoring, standard blood pressure measurements, weight, fingerstick for HbA1c point-of-care testing, and questionnaires.\n\nParticipants may also choose to participate in an optional blood draw for DNA Repair Capacity testing as a modifiable risk factor for aging-associated diseases.",[198,111,32,199],"Cognitive Decline","Aerobic Exercise",[201,202,203,204],"nutrition","cooking","exercise","hypertension","2026-02-03",{"date":207,"type":44},"2026-02-05",{"date":209,"type":44},"2023-11-28",{"date":211,"type":23},"2028-05-31",{"name":213,"class":51},"Indiana University",{"id":215,"slug":216,"hasResults":11,"nctId":217,"briefTitle":218,"officialTitle":219,"acronym":220,"eligibilityCriteria":221,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":222,"targetDuration":4,"studyType":24,"phases":224,"briefSummary":225,"conditions":226,"keywords":4,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":236,"lastUpdatePostDateStruct":237,"startDateStruct":239,"completionDateStruct":241,"leadSponsor":243,"locationsCount":79},"100611239","protein-supplementation-during-dialysis-prosed-100611239","NCT07237997","Protein Supplementation During Dialysis (PROSED)","Re-examining Nutrition in Dialysis Patients: Nutritional Losses and the Role of Supplementation (Part 2).","PROSED","Inclusion Criteria:\n\n* Age ≥ 18 years (no upper age limit)\n* Patients receiving maintenance dialysis for ≥ three months\n* Ability to provide informed consent\n\nExclusion Criteria:\n\n* Anticipated live donor kidney transplant and\u002For kidney recovery within the period of sample collection.\n* Anticipated change of dialysis modality within the period of sample collection\n* Severe malnutrition based on either:\n\n  * Renal 7-point Subjective Global Assessment (SGA) scores of 1-2\n  * Global Leadership Initiative Malnutrition (GLIM) Stage 2\n* Protein-losing enteropathy.\n* Persistent nephrotic syndrome with \\>3g\u002Fday urinary protein loss.\n* Active wounds or burns contributing to protein losses as judged by the investigator.\n* Current active acute inflammatory illness (likely to have catabolic effect in the opinion of the investigator).\n* Current malignancy based on recent (\\\u003C12 months) diagnosis and\u002For active treatment for malignancy and\u002For planned treatment for malignancy, excluding non-melanoma skin cancers.\n* Pregnancy (current or planned within duration of study) or breast feeding.\n* People with swallowing difficulties precluding safe ingestion (International Dysphagia Diet Standardization Initiative (IDDSI) level 0 thin fluid).\n* People receiving intradialytic parenteral nutrition or intra-peritoneal amino acids, or any other forms of artificial feeding\n* People prescribed levodopa\n* People who are receiving chronic glucocorticoid therapy (\\>10mg day prednisolone or equivalent for \\>7 days within preceding 90 days).\n* People who are consuming a protein dietary intake above 1.5g protein\u002Fkg\u002Fbody weight.\n* People who, in the opinion of the investigator, will be unable to comply with study protocol requirements.\n* People who are vegan or other religious based dietary restrictions which would prevent them taking the supplement.",{"count":223,"type":23},114,[26],"When a patient has dialysis some nutrients are lost in the process. Nutritional losses include protein, trace elements (i.e. zinc, copper and selenium) and water-soluble vitamins (Vitamins C and B). These nutrients are essential for normal body function, including a good immune system and nutritional status. For example, on average the protein losses during a dialysis session (the process where the blood is cleaned via a machine and special fluid) is equal to 6g of protein\u002Fday (which is the equivalent of the amount of protein in 1 egg). Protein needs for the general population are 0.8g protein per kg of body weight. Because people on dialysis lose protein via the dialysis, it is thought that these people need to eat more protein. Currently, in clinical practice for people receiving dialysis, the guidelines are to aim for 1.1 -1.4g of protein per kg of body weight. However, the research is old and very weak.\n\nDialysis treatments have changed over the past 40 years, and the investigator does not know if the replacement of these nutritional losses is important to how well people do on dialysis and if they have any effect on survival. Previous research is mostly limited to haemodialysis (a type of dialysis that requires a machine which cleans the patients' blood via special filters) and peritoneal dialysis (this is a type of dialysis which happens via the patients' tummy). There is no research on the nutritional supplementation in home HD and nocturnal HD. Our research will investigate if a higher protein provision leads to a reduction is hospital admissions and improved outcomes in patients receiving dialysis.",[227,228,229,230,231,32,232,233,234,235],"Dialysis Patients","Dialysis","Protein Energy Wasting","Protein Intake","High Protein Dietary Intake","Diet Therapy","Hospitalisation","Muscle Mass and Strength","Muscle Mass","2025-11-14",{"date":238,"type":44},"2025-11-20",{"date":240,"type":23},"2026-01-05",{"date":242,"type":23},"2029-10-30",{"name":244,"class":51},"University of Nottingham",{"id":246,"slug":247,"hasResults":11,"nctId":248,"briefTitle":249,"officialTitle":250,"acronym":251,"eligibilityCriteria":252,"healthyVolunteers":17,"sex":18,"minAge":253,"maxAge":4,"enrollmentInfo":254,"targetDuration":4,"studyType":162,"phases":4,"briefSummary":256,"conditions":257,"keywords":279,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":309,"lastUpdatePostDateStruct":310,"startDateStruct":312,"completionDateStruct":314,"leadSponsor":316,"locationsCount":79},"100469557","generation-victoria-cohort-2020s-a-statewide-longitudinal-cohort-study-of-victorian-children-and-their-parents-100469557","NCT05394363","Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents","Generation Victoria Cohort 2020s. A Statewide Longitudinal Cohort of Victorian Children and Their Parents","GenV","Inclusion Criteria (Children):\n\n* Birth date between 4th October 2021 and 3rd October 2023\n* Live at the time of recruitment\n* Residing in Victoria at the time of recruitment\n* Has a legally acceptable representative capable of understanding the informed consent document and providing consent on the child's behalf, who provides a signed and dated informed consent form (e.g. a parent\u002Fguardian)\n\nInclusion Criteria (Adults):\n\n* Be a parent or guardian of a child who meets the eligibility criteria above\n* Provide a signed and dated informed consent form or have a legally acceptable representative capable of understanding the informed consent document and providing consent on the participant's behalf.\n\nExclusion criteria:\n\n* Children who are deceased at the time of recruitment (i.e. still born or died after birth) and their parents\u002Fguardians\n* Families unable to provide informed consent in any of the languages available","1 Day",{"count":255,"type":23},150000,"Generation Victoria (GenV) is a longitudinal, population-based study of Victorian children and their parents that will bring together data on a wide range of conditions ,exposures and outcomes. GenV blends study-collected, study-enhanced and linked data. It will be multi-purpose, supporting observational, interventional, health services and policy research within the same cohort. It is designed to address physical, mental and social issues experienced during childhood, as well as the antecedents of a wide range of diseases of ageing. It seeks to generate translatable evidence (prediction, prevention, treatments, services) to improve future wellbeing and reduce the future disease burden of children and adults.\n\nThe GenV Cohort 2020s is open to all children born over a two-year period, and their parents, residing in the state of Victoria Australia. The GenV Cohort 2020s is preceded by an Advance Cohort of children born between 5 Dec 2020 and 3 October 2021, and their parents. This comprises all families recruited at GenV's Vanguard hospital (Joan Kirner Women's and Children's) and at birthing hospitals throughout Victoria as GenV scaled up to commence recruiting for the GenV Cohort 2020s. The Advance Cohort have ongoing and full participation in GenV for their lifetime unless they withdraw but may have less complete data and biosamples.",[258,259,260,261,262,263,264,265,266,267,268,99,269,270,271,272,273,274,275,276,32,140,277,107,278],"Mental Health","Child Wellbeing","Infant Health","Child Health","Reproductive Health","Healthy Aging","Health Equity","Quality of Life","Social Determinants of Health","Environmental Exposure","Genetics","Learning","Child Development","Congenital Abnormalities","Disability","Injuries","Communicable Diseases","Noncommunicable Diseases","Physical Fitness","Allergy and Immunology","Intergenerational Relations",[280,251,281,282,283,261,284,285,286,287,288,289,290,291,292,293,294,295,296,297,298,299,264,300,301,302,303,304,305,306,266,307,308],"Generation Victoria","Cohort Studies","Data Collection","Data Linkage","Midlife Health","Children","Infants","Family","Parents","Mothers","Fathers","Life course perspective","Population Health","Longitudinal Studies","Genetics, population","Demography","Epidemiology","Health Disparity","Minority Health","Vulnerable Populations","Clinical Trial","Randomized Controlled Trial","Pragmatic Clinical Trial","Health Services Research","Economic Models","Value of Life","Geographic Information Systems","Climate Change","Built Environment","2025-07-30",{"date":311,"type":44},"2025-08-03",{"date":313,"type":44},"2021-10-04",{"date":315,"type":23},"2033-10",{"name":317,"class":51},"Murdoch Childrens Research Institute",{"id":319,"slug":320,"hasResults":11,"nctId":321,"briefTitle":322,"officialTitle":322,"acronym":323,"eligibilityCriteria":324,"healthyVolunteers":17,"sex":18,"minAge":88,"maxAge":4,"enrollmentInfo":325,"targetDuration":4,"studyType":24,"phases":327,"briefSummary":328,"conditions":329,"keywords":335,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":340,"lastUpdatePostDateStruct":341,"startDateStruct":343,"completionDateStruct":345,"leadSponsor":347,"locationsCount":79},"100589558","the-effect-of-pectin-supplementation-on-geriatric-with-frailty-a-randomised-placebo-controlled-dietary-intervention-study-100589558","NCT06955975","The Effect of Pectin Supplementation on Geriatric With Frailty: A Randomised Placebo-Controlled Dietary Intervention Study","GEOFF","Inclusion Criteria:\n\n* Participant is willing and able to give informed consent for participation in the study.\n* Participant eligibility includes those aged \\>65 years who have a body mass index (BMI) between 18.5 and 39.9 kg\u002Fm2.\n* Participants who are considered as pre-frail or frail based on FRAIL (Simple Frailty Questionnaire).\n\nExclusion Criteria:\n\n* Have gastrointestinal conditions e.g. malabsorptive conditions such as IBS\u002FIBD, coeliac or functional conditions such as gastroparesis or food intolerances etc.\n* History of major surgery which potentially limit participation or completion of the study.\n* History of gastrointestinal resection surgery, including bariatric surgery.\n* Used of antibiotics, antifungal medications, probiotics or prebiotics 90 days before the start of the study.\n* Are taking the following medications: immunosuppressants, amiodarone and\u002For perhexiline.\n* Are currently following or anticipated to commence a specialised commercially available weight loss diet and\u002For program.\n* History of side effects towards probiotics or prebiotics.\n* History or current psychiatric illness.\n* History or current neurological condition (e.g. epilepsy).\n* Having taken part in a research study in the last 3 months involving invasive procedures or an inconvenience allowance.",{"count":326,"type":23},30,[26],"The study involves the intake of Low-methoxy (LM) pectin (polysaccharides extracted from citrus peels), which are commonly found in the UK diet (not pharmacological agents), to test their effects on systematic inflammation in the body and gut microbiome composition. Study subjects will be healthy elderly with early signs of frailty or pre-frailty from the local population and will be asked to attend the laboratory on 2 occasions; before and after 4-week' supplementing the diet daily with either 10g of pectin with 10g of whey protein and 10g of cocoa powder added as flavour (active arm) or 10g of whey protein with 10g of cocoa powder added as flavour (placebo). Participants will be given the blinded products portioned in individual sachets, with instructions to add the contents of one sachet a day to 150ml of milk and to consume immediately.\n\nAt each study visit (\\~90 minutes), participants will be asked to provide a stool and blood sample, will have blood pressure, heart rate, weight, height, and waist\u002Fhip ratio measured, research team will perform physical functioning test (Time up and go test, 30-second sit to stand test) as well as participants will complete the quality-of-life questionnaire (SF-36), the Depression and Anxiety (HADS) and the Gastrointestinal Symptom Rating Scale (GSRS).",[330,331,332,32,333,334],"Frailty at Older Adults","Pre-Frailty","Frailty","Dietary Fiber","Systemic Inflammatory Response",[336,337,332,331,338,114,339],"Pectin","LM Pectin","Systemic inflammation","Gut microbiome","2025-06-17",{"date":342,"type":44},"2025-06-22",{"date":344,"type":44},"2025-02-10",{"date":346,"type":23},"2026-03-31",{"name":244,"class":51},{"id":349,"slug":350,"hasResults":11,"nctId":351,"briefTitle":352,"officialTitle":353,"acronym":354,"eligibilityCriteria":355,"healthyVolunteers":11,"sex":356,"minAge":357,"maxAge":358,"enrollmentInfo":359,"targetDuration":4,"studyType":162,"phases":4,"briefSummary":361,"conditions":362,"keywords":4,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":367,"lastUpdatePostDateStruct":368,"startDateStruct":370,"completionDateStruct":372,"leadSponsor":374,"locationsCount":79},"100527218","norwegian-microbiota-study-in-anorexia-nervosa-100527218","NCT06144905","Norwegian Microbiota Study in Anorexia Nervosa","Gut Microbiota Alterations in Anorexia Nervosa - Paving the Way for Personalized Prebiotic Treatment Strategies","NORMA","Inclusion Criteria AN group\n\n1. Sex: Female\n2. Age: 16-50 years\n3. BMI: \\\u003C18.5 kg\u002Fm2\n4. fulfilling ICD-10 criteria for AN\n5. currently referred to specialized inpatient nutritional treatment for AN\n6. able to understand the Norwegian questionnaires.\n\nExclusion Criteria AND group:\n\n1. history of inflammatory bowel disease, celiac disease, or GI tract surgery;\n2. treatment with oral antibiotics the past two months\n3. high intake of probiotic supplements over the past two months.\n\nInclusion criteria control group\n\n1. Sex: Female\n2. Age: 16-50 years\n3. BMI: \\>= 18.5 \\& \\\u003C 27\n4. able to understand the Norwegian questionnaires.\n\nExclusion Criteria AND group:\n\n1. history of inflammatory bowel disease, celiac disease, or GI tract surgery;\n2. treatment with oral antibiotics the past two months\n3. high intake of probiotic supplements over the past two months.","FEMALE","16 Years","50 Years",{"count":360,"type":23},180,"Anorexia nervosa (AN) is a serious mental disorder occurring mainly in women. AN is characterized by severely restricted food-intake and subsequent low weight. The disease burden for the individual is high with medical complications and psychiatric comorbidities. Despite decades of research, there are large gaps in the understanding of the biological aspects of AN and lack of effective interventions. Current clinical treatment is associated with gastrointestinal problems, high rates of relapse and poor outcome causing long-term sickness absence and disability. During the COVID19 pandemic the prevalence and severity of AN has spiked. Therefore, there is great need of novel strategies for AN treatment, that can be easily implemented in the clinic without adding complexity to the standard care of treatment. During the resent years it has been proposed that mental disorders might be treated via manipulating the composition and function of the microbes that live in the gut (the microbiota) by adding or restricting fermentable nutrients (prebiotics) in the diet. However, in order to use prebiotics to treat the microbiota in AN patients, more knowledge is needed on how the AN microbiota is affected by the current standard care treatment. Whether prebiotics can be useful for normalizing AN microbiota remains to be established. The overall aim of the \"Norwegian study of Microbiota in Anorexia Nervosa\" (NORMA) is to join forces of researchers, clinical health care services and voluntary sector in a transdiciplinary approach to improve the understanding of the role of the gut microbiota in AN patients. The current project will include a clinical trial in AN patients and experimental studies to screen novel prebiotics for their ability to modify and normalize AN derived microbiota. The long-term goal of the project is to pave the way for a targeted and clinically feasible individualized treatment for better tolerable weight-restoration and improved health in AN patients.",[363,364,365,32,366],"Anorexia Nervosa","Mental Health Issue","Microbiota","Gastrointestinal Problems","2025-05-20",{"date":369,"type":44},"2025-05-23",{"date":371,"type":44},"2023-09-24",{"date":373,"type":23},"2043-09",{"name":375,"class":51},"Norwegian University of Life Sciences",{"id":377,"slug":378,"hasResults":11,"nctId":379,"briefTitle":380,"officialTitle":381,"acronym":4,"eligibilityCriteria":382,"healthyVolunteers":17,"sex":18,"minAge":383,"maxAge":384,"enrollmentInfo":385,"targetDuration":4,"studyType":24,"phases":387,"briefSummary":389,"conditions":390,"keywords":391,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":399,"lastUpdatePostDateStruct":400,"startDateStruct":402,"completionDateStruct":404,"leadSponsor":406,"locationsCount":79},"100579757","phase-1-increasing-affordable-fruits-and-vegetables-for-families-with-food-insecurity-100579757","NCT06828445","Increasing Affordable Fruits and Vegetables for Families With Food Insecurity","Increasing Use of SNAP Fruit and Vegetable Incentive Programs for Families With Food Insecurity","Inclusion Criteria:\n\n* Primary caregiver 18+ years of age\n* Has a child 2-10 years of age\n* Speaks English\n* Screens positive for food insecurity\n* Currently enrolled in the Supplemental Nutrition Assistance Program (SNAP)\n* Lives with a feasible radius for home delivery\n* Consistent access to a phone that receives text messages\n\nExclusion Criteria:\n\n* Anticipate no longer being enrolled in SNAP during the study duration\n* Recent use of the SNAP fruit and vegetable incentive program\n* Caregiver or child has a medical condition that impacts their ability to eat fruits and vegetables\n* Caregiver or child has a significant food allergy, preference, or intolerance that impacts their ability to eat fruits and vegetables","2 Years","10 Years",{"count":386,"type":23},296,[388],"PHASE1","Investigator will test an intervention to increase use of a fruit and vegetable incentive program in South Carolina for families in the Supplemental Nutrition Assistance Program (SNAP) experiencing food insecurity. Caregivers are randomized to an intervention or an education-only, wait-list control group. The investigators hypothesize the intervention will improve diet-related outcomes, above and beyond the education-only wait-list control.",[32],[392,393,394,395,396,397,398],"food insecurity","diet","Supplemental Nutrition Assistance Program","fruit","vegetable","healthy eating","pediatrician","2025-04-03",{"date":401,"type":44},"2025-04-04",{"date":403,"type":44},"2025-03-06",{"date":405,"type":23},"2029-01",{"name":407,"class":51},"University of South Carolina",{"id":409,"slug":410,"hasResults":11,"nctId":411,"briefTitle":412,"officialTitle":413,"acronym":4,"eligibilityCriteria":414,"healthyVolunteers":11,"sex":18,"minAge":19,"maxAge":4,"enrollmentInfo":415,"targetDuration":417,"studyType":162,"phases":4,"briefSummary":418,"conditions":419,"keywords":422,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":425,"lastUpdatePostDateStruct":426,"startDateStruct":428,"completionDateStruct":430,"leadSponsor":432,"locationsCount":79},"100579570","trectamu-cancer-prevention-registry-and-repository-100579570","NCT06826014","TREC@TAMU Cancer Prevention Registry and Repository","Texas Regional Excellence in Cancer (TREC) @Texas A&M University Cancer Prevention Registry and Repository","Inclusion Criteria:\n\n* 18 years of age and older, and,\n* People participating in the Cancer Prevention and Research Institute of Texas (CPRIT) A coordinated cancer screening research program in Bryan and Navasota Family Medicine Clinics and,\n* People with COPD, liver disease, cervical intraepithelial neoplasia (CIN) lesions, having had a colonoscopy or a low dose computed tomography (LDCT) lung scan or cervical exam in the last 12 months or scheduled for one, and,\n* Able to give and comprehend the consent process, and,\n* Able to consent to donate blood and urine samples, genetic material through buccal swabs for future research, and,\n* Able to understand that their specimens, health record, and changes in health status will be followed for a five-year period and shared in deidentified form with the research community, and,\n* All sexes and gender identities.\n\nExclusion Criteria:\n\n* Declines to participate or interact with staff\u002Fshare their medical status.\n* A diagnosis of Alzheimer's disease or related dementias in a medical record indicates a progressive, debilitating condition that impairs memory, thought processes, and functioning Individuals who are unable or unwilling to provide consent will be excluded",{"count":416,"type":23},2500,"5 Years","This study collects health and genetic information to implement cancer prevention and treatment strategies.",[141,268,420,32,421],"Disease","Lifestyle Factors",[423,424],"cancer","genetics","2025-02-11",{"date":427,"type":44},"2025-02-13",{"date":429,"type":23},"2025-03",{"date":431,"type":23},"2030-11",{"name":433,"class":51},"Texas A&M University",{"id":435,"slug":436,"hasResults":11,"nctId":437,"briefTitle":438,"officialTitle":439,"acronym":4,"eligibilityCriteria":440,"healthyVolunteers":17,"sex":18,"minAge":19,"maxAge":441,"enrollmentInfo":442,"targetDuration":4,"studyType":24,"phases":444,"briefSummary":445,"conditions":446,"keywords":4,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":449,"lastUpdatePostDateStruct":450,"startDateStruct":452,"completionDateStruct":454,"leadSponsor":456,"locationsCount":79},"100574007","healthy-plant-based-diet-and-periodontal-treatment-100574007","NCT06753682","Healthy Plant-based Diet and Periodontal Treatment","Effect of the Healthy Plant-based Dietary Pattern as an Adjunct to Non-surgical Periodontal Treatment in Periodontitis: A Randomized Controlled Clinical Trial","Inclusion Criteria:\n\n* Chinese ethnicity aged between 18 and 64;\n* Generalized Stage II and Stage III periodontitis;\n* at least 10 occluding pairs present;\n* Good general health;\n* Never-smoker or former smoker who had quit smoking successfully for at least 12 months prior to the screening visit;\n* Body mass index (BMI) ranging between 18.5 and 28 kg\u002Fm2;\n* Self-reported inadequacy of hPBD with the main focus on fresh vegetables (\\<300 g\u002Fday) or\u002Fand fruit (\\<200 g\u002Fday) with reference to the Dietary Guidelines for Chinese residents (Society, 2022).\n\nExclusion Criteria:\n\n* Edentulism\n* Presence of any systemic disease or taking medication that can alter the manifestation\u002Foutcome of periodontal treatment (e.g., uncontrolled diabetes mellitus, hypertension with use of calcium channel blocker, etc.)\n* Pregnancy or intention to become pregnant at any point during the study duration\n* Need for antibiotic prophylaxis in the context of dental treatment\n* Having received non-steroidal anti-inflammatory medication or antibiotics within the previous 3 months\n* Having received professional periodontal treatment (other than supragingival cleaning) within the previous 12 months\n* History or clinical manifestation of any eating disorder as determined the International Classification of Diseases\n* Presence of any dietary restriction (e.g., adherence to a Mediterranean diet), currently taking nutrient supplements or inability to choose his\u002Fher diet\n* Having obvious weight change (≥5% of current body weight) over the past 6 months\n* Participation in another intervention trial\n* Inability or unwillingness of individual to give written informed consent","64 Years",{"count":443,"type":23},78,[26],"Background:\n\nPeriodontitis is a highly prevalent chronic disease, affecting around 743 million people globally. In Hong Kong, over 90% of adults have bleeding gums, and 50% of the elderly have severe periodontitis.\n\nThe causes of periodontitis are complex, involving polymicrobial dysbiosis, chronic inflammation, immune response, and environmental factors. Current treatments focus on oral hygiene, biofilm\u002Fcalculus removal, and surgery for advanced cases. While lifestyle and risk factor modifications can improve treatment outcomes, only a few modifiable factors, like smoking cessation and diabetes control, have been established. Identifying more modifiable risk factors and implementing effective interventions are crucial to address this significant public health issue.\n\nDiet has shown to be a major modifiable risk factors in pathophysiology of diabetes mellitus and cardiovascular diseases. The recent Global Burden of Diseases (GBD) study also supports this by pointing out the key dietary risk factors for chronic diseases and mortality. Nonetheless, the role of dietary intervention in the field of periodontitis is poorly understood.\n\nThe evidence of a plant-based dietary pattern, defined by a higher consumption of plant foods and lower intake of animal foods, on preventing and treating NCDs is emerging and a \"healthy plant-based dietary pattern\" is shown to lower risk of periodontitis and elevated serum antibody levels against periodontopathogens. \"Healthful plant-based dietary pattern\" mainly comprises of high consumption of healthy plant food (e.g., whole grains, fruit and vegetable), but low proportion intake of unhealthy plant food (e.g., refined grains, fruit juices, and sugar-sweetened beverages) .\n\nAlthough the cross-sectional data from National Health and Nutrition Examination Survey (NHANES) shows promising benefits of the healthful plant-based diet, it is still inconclusive whether \"healthful plant-based dietary pattern\" is beneficial in preventing and treating periodontal disease. Therefore, it is planned to carry out a high quality, randomised controlled trial to support advocating this dietary pattern in periodontal patients.\n\nHypothesis:\n\nIt is hypothesized that non-surgical periodontal treatment (NSPT) performed in conjunction with healthful plant-based diet would provide additional clinical, immunological and microbiological benefits without incurring malnutrition periodontitis patients\n\nMaterials and Methods:\n\n1. Recruitment of subjects\n\n   1. Patients diagnosed with Stage II and Stage III Periodontitis will be recruited from the Reception and Primary Care Clinic of the Prince Philip Dental Hospital and the Institute for Advanced Dentistry, The University of Hong Kong.\n   2. Participants enrolled will be randomized into two groups, one test group and one control group (with or without dietary intervention on healthy plant-based diet)\n2. Study Procedures\n\n   1. Baseline examination At baseline, besides the routine periodontal examination, patients will undergo dietary assessment by performing the Food Frequency Questionnaire (FFQ), anthropometric measures, oral health related quality of life and physical activity assessment . Biological samples for instance the blood, saliva, fecal and subgingival plaque will also be collected.\n   2. Periodontal treatment Step I and Step II periodontal therapy including, oral hygiene instructions, control of risk factors, extraction of hopeless teeth, if any, scaling and root surface debridement will be provided to both groups\n   3. Dietary intervention The participants in the test group will participate in a 3-month active intervention phase, a 3-month reinforcement phase, and a 6-month maintenance phase, with the intervention delivered by a trained and registered dietitian. The participants in the control group will continue the ad libitum diets based on their current eating habits and receive no dietary interventions..\n   4. Recall Schedule The follow-up visits will be conducted at 2 weeks, 4 weeks, 3, 6 and 12 months after completion of the debridement.\n\nSignificance:\n\nThis study will provide local data and explore whether healthful plant-based diet as an adjunct to non-surgical periodontal treatment can improve clinical outcome, and provide scientific evidence of its effect on clinical, immunological and microbiological markers of periodontitis.\n\nThis can help us understand more on the relationship of healthful plant-based diet and periodontal diseases, which may eventually provide new perspectives for treatment of patients with periodontitis.",[447,448,32],"Periodontal Diseases","Periodontitis","2024-12-29",{"date":451,"type":44},"2024-12-31",{"date":453,"type":44},"2024-09-01",{"date":455,"type":23},"2026-05-31",{"name":457,"class":51},"The University of Hong Kong"]